Web Results

Sanofi

en.wikipedia.org/wiki/Sanofi

In 1993 Sanofi made a move into the Eastern Europe market ... Sanofi- Synthélabo was formed in 1999 when Sanofi ...

Sanofi U.S. - Sanofi US researches, develops and brings to market ...

www.sanofi.us/

Find Sanofi US corporate information, pharmaceutical products, news, career opportunities and health resources.

Sanofi - Un leader mondial de la santé centré sur les besoins des ...

www.sanofi.com/

Sanofi, un leader mondial de la santé centré sur les besoins des patients, doté d' une offre diversifiée de médicaments de prescription, de santé grand public, de ...

Sanofi-Synthelabo lands Aventis for $64 billion - Apr. 26, 2004

money.cnn.com/2004/04/26/news/international/aventis_sanofi/

Apr 26, 2004 ... NEW YORK (CNN/Money) - France's largest drugmaker Aventis will stay under French control after smaller rival Sanofi-Synthelabo raised its ...

Aventis vs. Sanofi-Synthelabo - Biggest Battles in Biopharma ...

www.fiercepharma.com/special-report/aventis-vs-sanofi-synthelabo-biggest-battles-biopharma

Aventis vs. Sanofi-Synthelabo In January 2004, a hopeful, scrappy Sanofi- Synthélabo officially announced that it was making a $60 billion bid to take over ...

Sanofi | LinkedIn

www.linkedin.com/company/sanofi-

Learn about working at Sanofi. Join LinkedIn today for free. See who you know at Sanofi, leverage your professional network, and get hired.

Contact us - Sanofi U.S.

www.contactus.sanofi-aventis.us/

For more specific requests, you can send a brief online form (noted by Image of Document Icon in the list below) to the appropriate Sanofi US contact or you can  ...

Sanofi-Aventis | French company | Britannica.com

www.britannica.com/topic/Sanofi-Aventis

French pharmaceutical company founded in 2004 through the merger of Sanofi- Synthélabo SA and a much larger French firm, Aventis. Primarily focused on the ...

Rimonabant Sanofi-Synthélabo. - NCBI

www.ncbi.nlm.nih.gov/pubmed/15134285

Curr Opin Investig Drugs. 2004 Apr;5(4):430-5. Rimonabant Sanofi-Synthélabo. Fernandez JR(1), Allison DB. Author information: (1)University of Alabama at ...

Pleconaril Sanofi Synthélabo/ViroPharma. - NCBI

www.ncbi.nlm.nih.gov/pubmed/11249712

Pleconaril is an oral antiviral agent being developed by ViroPharma and Sanofi- Synthélabo (formerly Sterling Winthrop) for the potential treatment of several ...

More Info

Sanofi-Synthelabo Inc.

www.sanofi-synthelabous.com

Sanofi-Synthelabo annual report 2001

en.sanofi.com

2001 was fundamentally even better for Sanofi-Synthélabo. ... Sanofi- Synthélabo's sales force, which comprised 1,155 medical sales representatives at the end ...

Sanofi in India - Sanofi-Synthelabo (India) Private Limited

www.sanofi.in

Oct 1, 2015 ... Healthcare professionals seeking abbreviated prescribing information of the prescription product portfolio of Sanofi-Synthelabo (India) Private ...